Home

Hans van Houte, CFO: Nurix Therapeutics NRIX Sell · Filed 05/05

Trade details

Type
Insider sale
Amount
$9,998.76
Shares · price
582 sh · $17.18 a share
Held after
37,592 sh
Trade date
26/05/05
Filed
26/05/05
Days to filing
0 days

Sold 1.5% of holdings

Share of holding sold
1.5%

Nurix Therapeutics trades, last 26 weeks

What else happened in Nurix Therapeutics around then

Filed or reported within 30 days of the trade day · 04/05~06/04

Hans van Houte's recent trades

  • Hans van Houte

    Planned sale10b5-1 planNurix Therapeutics

    $110.6K

    Filed 08/04

  • Hans van Houte

    Sell10b5-1 planNurix Therapeutics

    $223.4K

    Filed 05/05

  • Hans van Houte

    Planned sale10b5-1 planNurix Therapeutics

    $238K

    Filed 05/05

  • Hans van Houte

    SellNurix Therapeutics

    $39.8K

    Filed 04/30

  • Hans van Houte

    SellNurix Therapeutics

    $59.5K

    Filed 01/30

Hans van Houte, CFO — sold $9,999 of Nurix Therapeutics NRIX · 1.5% of holdings · 10b5-1 plan | Whalegun